Who
Thomas A. McCourt
Director
Company insider
Files Form 4 as: Director, Pliant Therapeutics; Chief Executive Officer, Ironwood Pharmaceuticals; Director, Acceleron Pharma.
In numbers
- Trades disclosed
- 154
- Buys
- 0
- Sells
- 39
- Bought
- $0
- Sold
- $19.2M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 2 Feb 2010
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | PLRX Pliant Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | PLRX Pliant Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —409,836 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —409,836 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $379K103,526 at $3.66 | filing |
| 24 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $379K103,526 at $3.66 | filing |
| 23 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $361K94,757 at $3.81 | filing |
| 23 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $361K94,757 at $3.81 | filing |
| 5 Jun 2025filed 9 Jun 2025 | PLRX Pliant Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 20 May 2025filed 20 May 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —540,000 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $7,74513,353 at $0.58 | filing |
| 10 Feb 2025filed 12 Feb 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $245K139,064 at $1.76 | filing |
| 17 Jan 2025filed 22 Jan 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —147,354 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | PLRX Pliant Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,764 at $0.00 | filing |
| 20 May 2024filed 22 May 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $436K67,618 at $6.45 | filing |
| 8 Mar 2024filed 12 Mar 2024 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —120,298 at $0.00 | filing |
| 8 Mar 2024filed 12 Mar 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —120,298 at $0.00 | filing |
| 5 Mar 2024filed 7 Mar 2024 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —132,438 at $0.00 | filing |
| 5 Mar 2024filed 7 Mar 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —264,876 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $2.7M177,164 at $15.24 | filing |
News
No headline names them, or the companies they trade most, lately.